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Background: Anorexia nervosa (AN) is associated with high rates of chronicity and relapse risk is a considerable
therapeutic challenge in the disorder. The aim of the present study was to investigate the association of stages of
change and outcome with a focus on the relapse struggle in the maintenance stage in patients with
predominantly chronic AN. Further, therapeutic alliance and stages of change associations were explored.
Methods: As an instrument measuring relapse struggle in the maintenance stage, we applied the short form of the
University of Rhode Island Change Assessment-Short (URICA-S). We assessed stages of change in 39 patients with a
predominantly chronic course of AN in early, middle, and late stages of inpatient psychotherapy. General symptom
severity as assessed by the SCL-90-R and weight change were investigated as outcome measures.
Results: In-line with earlier evidence, contemplation significantly predicted therapeutic alliance. Further, we
demonstrated that relapse risk as operationalized by URICA-S maintenance is an important predictor of general
psychopathology. BMI change was not predicted by stages of change.
Conclusions: The URICA-S maintenance scale might be applied to help identify patients at relapse risk. High
URICA-S maintenance scores could be considered as one critical aspect of AN patients who might especially benefit
from relapse-preventing aftercare programs.
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Transtheoretical modelBackground
Anorexia nervosa (AN) has been recognized as a severe
disorder that is challenging to treat. This is partly re-
flected by the often long and severe course of the
disorder, which in many patients is characterized by re-
current treatment attempts and dropouts, rehospitaliza-
tion, high rates of relapses and chronicity [1-3]. The
comparably large group of patients with long-lasting
problems and a chronic course has been identified as be-
ing particularly difficult to treat and having poor treat-
ment outcomes [4]. Generally, evidence on treatment
approaches for long-standing AN is very limited [4] and
more knowledge on predictors of treatment response
and resistance in AN patients could inform the further* Correspondence: martin.teufel@med.uni-tuebingen.de
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reproduction in any medium, provided the ordevelopment of such approaches. Therefore, the aim of
the present study was to investigate the association of
the motivational stages of the patient with treatment
outcome variables and therapeutic alliance in chronic
AN patients.
One major challenge that has been identified in AN
treatment is the ambivalent motivation for change and
treatment in affected patients. This ambivalence has been
associated with the pronounced egosyntonicity of AN
symptoms, including severe underweight, as a remarkable
feature of the disorder, which constitutes a major barrier
to behavioral change [5]. Two approaches targeting mo-
tivation in therapeutic change are the Transtheoretical
Model (TTM) by Prochaska & DiClemente [6,7], as a
more theoretical framework, and Motivational Intervie-
wing [8], as a treatment approach specifically targeting
the enhancement of motivation. Both approaches havel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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including AN [9]. The TTM suggests that therapeutic
interventions should be adapted to the motivational stage
of the patient. It distinguishes four empirically vali-
dated stages of change: In the precontemplation stage,
patients have no intention for a therapeutic change.
In the contemplation stage, patients ambivalently think
about therapeutic change. In the action stage, active work
on therapeutic change is central and in the maintenance
stage, patients focus on relapse prevention. One central
assumption of the TTM is that patients move through the
stages of change in a spiral pattern. Hence, relapses are
regarded as integral parts in the change cycle [10]. The
most widely used dimensional instrument to measure the
stages of change is the University of Rhode Island Change
Assessment (URICA, [11]). Recently, a short version with
excellent psychometric properties has been constructed
[12]. A meta-analysis found robust effect size of d = .46 for
the association between URICA stages of change and out-
come [13]. The URICA comprises several items that
clearly reflect relapse struggle [12,14]. Hence, it is an in-
strument that specifically identifies patients at relapse risk.
This is of importance concerning AN research, because,
as we have outlined above, high rates of relapses and
chronicity are critical elements in AN treatment [15].
In their recent review, Dray & Wade [9] point out that
while there is first evidence that the TTM is applicable
to eating disorders and the stages of change are associ-
ated with treatment outcome in affected patients, only
few studies have been conducted and more research is
needed. The investigation of different patient samples
(e.g. age groups, patients with a chronic course), a broader
focus on different relevant treatment outcomes, and the
consideration of the therapeutic alliance have been identi-
fied as major research gaps [9]. To our knowledge, there
are currently only three studies published on the predict-
ive value of stage of change on treatment outcome in AN
patients [16-18], two of which were conducted in adoles-
cent samples. All of them report on a global score of
stages of change as an indicator of motivation to change
and identified this global score as a positive predictor of
weight gain, improvement of eating disorder pathology,
and composite improvement outcome at discharge [17,18]
as well as of weight maintenance after discharge [16].
In the present study, we have investigated the predic-
tive value of stages of change in an adult sample of pa-
tients receiving inpatient treatment for AN. As outlined
above, relapses and chronicity are major concerns in AN
treatment. Hence, we investigated adult patients who
suffered at least one year from full syndromal AN, and
predominantly focused on chronic patients. Comple-
menting earlier evidence and addressing current research
gaps outlined by the recent review by Dray & Wade [9],
we have focused on different relevant outcomes in ANtreatment, including weight gain, general psychopath-
ology, and therapeutic alliance. In-line with earlier evi-
dence on the role of stages of change in the therapeutic
process of inpatient psychotherapy by our work group
[12], we hypothesized that lower ratings on precontem-
plation as well as higher ratings on contemplation and
action are associated with a better outcome in adult
AN inpatients in terms of weight gain and improvement
of general psychopathology. Further, we presumed that
higher ratings on the maintenance scale are associated
with a more negative outcome, because the maintenance
score of the URICA-S reflects the struggle with relapses
[12]. Turning to the therapeutic alliance, we hypothesized
in-line with earlier evidence [19] that contemplation at an
earlier stage of therapy is positively associated with the al-
liance at a later stage of therapy. We further hypothesized
that precontemplation and maintenance at earlier stages
of therapy would be negatively associated while action
would be positively associated with therapeutic alliance at
later stages of therapy.
Method
Measures
All patients were medically assessed with the Structured
Clinical Interview for DSM-IV, German version (SCID-I,
[20]). The German version of the Symptom-Checklist-
90-Revised (SCL-90-R, [21]) was administered to all pa-
tients as a measure of general symptom severity. The
German version of the Symptom-Checklist-90-Revised
(SCL-90-R, [21]) is a measure of general symptom
severity. It consists of eleven subscales, with 90 items
on a 5-stepped scale. It showed excellent internal con-
sistencies, with .79 ≤ α ≤ .89 and good retest-reliabilities,
with .69 ≤ r ≤ .92, and acceptable construct validity, with
scale-outcome correlations between .27 ≤ r ≤ .81.
Further, each patient filled in the German short form
of the URICA (URICA-S [12]). The original long form of
the URICA consists of 32 items with 8 items for each of
the 4 subscales precontemplation, contemplation, action,
and maintenance. The URICA-S consists of 16 items
rated on a scale from 0 (very untrue) to 4 (very true)
and measures four stages of change (precontemplation,
contemplation, action, maintenance) with 4 items per
subscale. In a sample of 253 patients, Mander et al. (12)
demonstrated an excellent factor structure with factor
loadings of .52 ≤ λ ≤ .87. Confirmatory factor analyses
supported the exploratory model. The instrument re-
vealed acceptable to excellent internal consistencies,
with .61 ≤ α ≤ .84. The measure demonstrated high cor-
relations to the subscales of the original long form of the
URICA, with .83 ≤ r ≤ .96. Referring to the criterion-
related validity, outcome was significantly predicted by
the contemplation, action, and maintenance subscales as
well as by the committed action global score. As the
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relapses, it might be especially important to identify pa-
tients at risk for further chronicity. Therefore, more
negative values in maintenance reflect more problems
with relapses.
Each patient completed the Scale for the Multipers-
pective Assessment of General Change Mechanisms in
Psychotherapy (SACiP) [22]. It is a measure with the six
dimensions resource activation, problem actuation, mas-
tery, clarification of meaning, emotional bond, with three
items each and agreement on collaboration, which com-
prises the aspects tasks and goals, with six items. The
two dimensions emotional bond and agreement on col-
laboration refer to Bordin´s [23] concept of the thera-
peutic alliance. The SACiP consists of 21 items, which
are rated on a 5-stepped scale ranging from 0 (not cor-
rect at all) to 4 (fully correct) with correspondingly for-
mulated items from patient and therapist perspective.
The measure demonstrated an excellent factor structure
with factor loadings of .51 ≤ λ ≤ .85. Confirmatory factor
analyses supported the exploratory model. The instru-
ment revealed good to excellent internal consistencies,
with .71 ≤ α ≤ .90. Referring to the criterion-related valid-
ity, outcome was significantly predicted by all change
mechanisms except for problem actuation.
Treatment and study design
Specific inclusion criteria were a SCID-I primary diagno-
sis of full-syndrome AN. General exclusion criteria were
as follows: (1) Duration of disorder of less than one year,
(2) an age below 18 or above 59 years, (3) insufficient
German language skills, (4) psychotic or substance-
related disorders. All patients completed an inpatient
treatment at the Department of Psychosomatic Medicine
and Psychotherapy of Tübingen University, Germany. The
treatment consisted of individual therapy, group therapy,
art therapy, and music therapy two times a week. Psy-
chotherapy comprised a cognitive-behavioral therapy with
supplementary interpersonal psychotherapeutic elements.
Eight (7 female) psychotherapists with at least one year of
experience conducted therapy. Individual therapy was
conducted two times a week. Duration of inpatient treat-
ment comprised a minimum of 16 and a maximum of
84 days, with a mean of 48.8 (SD 16.4). Median of treat-
ment was 48.5 days. Patients below the median had a
mean treatment duration of 33.9 (SD 8.6) days and pa-
tients above the median had a mean treatment duration of
60.7 (SD 9.7) days. Patients were assessed at baseline (t1),
after the 7th session (t2) and after the last session (t3), re-
spectively. The patients with a shorter treatment duration
than 30 days were assessed only at 2 measuring times.
The initial SCID-I assessment was conducted by three
PhD-students who completed a university-based training.
A university-affiliated expert regularly supervised them.The local ethics committee of the medical faculty of
the university of Tübingen approved the study proto-
col (project number 29/2009B02) in accordance with
the Helsinki Declaration. All participants provided written
informed consent prior to study participation.
Statistical analyses
To identify empirical associations between stages of
change and outcome as well as therapeutic alliance, we
first of all calculated a set of correlational analyses. Fur-
ther, concerning general psychopathology, we calculated
three hierarchical regression analyses where we block-
wise entered the four URICA-S subscale scores as well
as the autoregressor (SCL-90 global severity index at t1),
one for each measuring time. As the dependent variable,
we always used the SCL-90 global severity index at t3. In
the first block, we entered the autoregressor of the
SCL-90. In the second block, we always entered the
maintenance score because it demonstrated the highest
association to therapy outcome in the correlational ana-
lysis. The order in which the other subscales were en-
tered in the following blocks depended on the strengths
of their correlations with therapy outcome. In a similar
way, we implemented predictive models for BMI at t3
and therapeutic alliance at t3 as the dependent variables.
Results
Clinical and socio-demographic sample description
Thirty-nine inpatients treated for AN participated in the
study. Complete data sets were available for 35 patients
and for 28 at the end of treatment. The demographic
data did not significantly differ between the full sample
and the sample at the end of treatment. A total of 97.1%
of patients were female. On average, patients were 27.7
(SD 10.63) years of age; 23.1% were married, 41.0% lived
with parents, 35.9% had an A-level degree, 38.5% had a
formal professional qualification, 20.5% were employed,
35.9% were still in job training and 20.4% were un-
employed. The percentage of patients with a diagnosis of
a major depression as comorbidity was 56.4%. Average
BMI at therapy entrance was 14.94 kg/m2 (SD 1.96),
with a minimum of 11.50 and a maximum of 17.40.
Average BMI at end of therapy was 16.19 (SD 2.04) with
a minimum of 12.00 and a maximum of 20.16. Mean dur-
ation of full syndromal AN was 8.6 years (SD 8.84), with a
minimum of 1 and a maximum of 27 years and a median
of 3.0 years. The percentage of those having a 1 to 3 year
duration of the disorder was 45.7%, while 22.9% had a dur-
ation of the disorder between 3 and 6 years and 31.4% had
a duration of the disorder of more than 6 years.
Stages of change association to treatment outcome
Correlational analyses revealed that the association of
maintenance with the SCL-90 was highly significant,
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BMI. Precontemplation was neither associated with the
SCL-90 nor with the BMI. Association of contemplation at
t2 with the SCL-90 was tentatively positive and with the
BMI at t3 was significantly positive. Association of action
at t2 and t3 was tentatively negative with the SCL-90 and
positive with the BMI. Concerning stages of change and
therapeutic alliance associations, correlational analyses re-
vealed, as predicted, that association of precontemplation
at t1 was significantly negative and contemplation at t1 was
significantly positive with emotional bond and agreement
on collaboration. For action and maintenance, no signifi-
cant effects were observable. Correlational coefficients are
depicted in Table 1.
Stages of change as predictors of treatment outcome and
therapeutic alliance
For all three measuring times, only the maintenance
scale proved to be a significant predictor of outcome.
The maintenance score was a significant predictor of
outcome at t1, R
2 = .60, p < .001; at t2, R
2 = .62, p < .001;
and t3, R
2 = .53, p < .001. None of the other stages of
change proved to be a significant predictor in any re-
gression model. We found no significant predictive effect
on BMI for any of the stages of change. ConcerningTable 1 Correlations of the URICA subscales at all three
measuring times with SCL, BMI, and therapeutic alliance
at the end of therapy
Precontemplation Contemplation Action Maintenance
SCL-90
t1 .09 .08 −.05 .51**
t2 −.11 .34 −.37 .56**
t3 .16 −.03 −.31 .55**
BMI
t1 −.02 .01 .17 −.22
t2 −.13 .39 .19 .28
t3 .07 .24 .33 −.28
BMI change t1 - t3
t1 −.07 −.07 −.08 .02
t2 .40* −.12 .04 .06
t3 .15 −.07 −.14 −.18
Emotional bond
t1 −.51* .51* .08 .02
t2 .21 .19 .03 .23
t3 .32 .10 .08 .14
Agreement on collaboration
t1 −.50* .46* .29 .19
t2 −.38 .24 .11 .23
t3 −.03 .30 −.01 .14
t1/t2/t3 = at baseline/7
th/last therapy session; * = p < .05; ** = p < .01; *** = p < .001.predictive effects on therapeutic alliance, the contem-
plation score significantly predicted emotional bond,
R2 = .45, p < .01; as well as agreement on collaboration,
R2 = .40, p < .01. None of the other stages of change
proved to be a significant predictor in any regression
model. For parsimonious reasons, we report only the
significant regression models concerning therapeutic
outcome in Table 2 and concerning therapeutic alliance
in Table 3.
Discussion
The aim of the present study was to investigate the asso-
ciation of stages of change according to the TTM [6,7]
with different treatment outcome variables in a sample
of predominantly chronic full syndromal AN patients.
Addressing current research gaps outlined by a recent
review [9], we investigated the predictive value of stages
of change for weight gain as assessed by changes in BMI,
general psychopathology as assessed by the SCL-90, and
therapeutic alliance as assessed by the SACiP [22]. As we
investigated a mainly chronic sample and because high re-
lapse rates are known to be one of the core problems of
AN treatment, we applied the URICA-S as a measure of
stages of change because its maintenance scale reflects re-
lapse threat [12,14]. (See Appendix for detailed wording of
the items of the maintenance scale).
To our knowledge, our study is the first analyzing
outcome profiles in AN patients for discrete stages of
change. The few earlier studies available predicted out-
come by applying a global score [16-18]. We were espe-
cially interested in therapy processes in patients treated
for chronic AN, and our sample therefore shows a high
average duration of illness of about 9 years.
We identified significant predictive effects of the main-
tenance scale on general psychopathology for all three
measuring times. The higher the maintenance score, that
is, the higher the struggle of patients with relapses, the
higher general psychopathology in the SCL-90. No other
stages-of-change scales resulted in additional predictive ef-
fects on therapeutic outcome in the regression models.
Hence, the maintenance score of the URICA-S as an indi-
cator of relapse threat obviously is especially important to
identify AN patients who improve during inpatient treat-
ment and those who suffer from repeated drawbacks. In
many patients, the course of AN is characterized by recur-
rent relapses, and the first time after hospital discharge
seems to be a specifically vulnerable phase [15,24]. It
might therefore be speculated that those patients who
score lower on maintenance, that is, who struggle less
with relapses, have taken a perspective on their disorder
that understands recovery as a process incorporating
relapses, and have developed strategies to cope with draw-
backs and both could facilitate the success of inpatient
treatment. This, in turn, would first underline the
Table 2 Significant linear regression coefficients of stages of change predicting SCL-90 symptomatology at the end of
therapy (N=26)
95% CI
B SE B β t p Lower bound Upper bound R2
Model 1: Maintenance t1 .60
Constant −.14 .20 −.70 .490 −.55 .27
SCL-90 baseline .67 .15 .61 4.38 <.001 .35 .98
Maintenance t1 .17 .07 .34 2.43 .023 .03 .31
Model 2: Maintenance t2 .62
Constant −.19 .21 −.90 .38 −.64 .25
SCL-90 baseline .65 .16 .58 4.03 .001 .31 .98
Maintenance t2 .20 .08 .38 2.59 .017 .04 .36
Model 3: Maintenance t3 .53
Constant −.08 .26 −.31 .760 −.62 .46
SCL-90 baseline .58 .20 .52 .29 .010 .16 1.0
Maintenance t3 .16 .09 .34 1.9 .08 −.20 .35
t1/t3 = at baseline/end of therapy. Model 1 / Model 2 / Model 3 = significant stages of change predictors at baseline/7
th/last therapy session for SCL-90 at the end
of therapy.
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into inpatient treatment programs for AN patients as, e.g.
education and skills training related to drawbacks and
relapses, and would second underline the importance of
relapse prevention interventions following inpatient treat-
ment. Both approaches might improve the course of the
disorder, particularly in patients with long-standing prob-
lems, as Long, Fitzgerald and Hollin [25] recently reported
in a prospective follow-up study that those chronic AN
patients had a better outcome who received continuity of
care, that is, who had outpatient treatment immediately
following inpatient care. The URICA maintenance scale
might be applied as one aspect of a relapse identification
tool, which could be used to identify subgroups of AN pa-
tients who might especially benefit from such relapse-
addressing aftercare programs [9,26].Table 3 Significant linear regression coefficients of stages of
alliance at the end of therapy (N=22)
B SE B β t
Model 1: Emotional bond at t3
Constant .71 .62 1
Emotional bond t1 .40 .16 .44 2
Contemplation t1 .41 .17 .42 2
Model 2: Agreement on collaboration at t3
Constant .35 −67 .5
Agreement on Collaboration t1 .47 .19 .44 2
Contemplation t1 .41 .19 .38 2
t1 = at baseline. Model 1 = stages of change at baseline significantly predicting emo
significantly predicting agreement on collaboration at the end of therapy.In our study, stages of change surprisingly had no pre-
dictive effect on BMI. This is in contrast to an earlier
study where Castro-Fornieles et al. [16] identified stages
of change as a highly significant predictor of BMI at dis-
charge. Possibly, this may be attributed to the different
measures applied to define stages of change and differ-
ent samples under investigation. While we are reporting
data of adult patients with long-lasting full syndromal
AN, Castro-Fornieles et al. [16] investigated an adoles-
cent sample. According to state-of-the- art practice in
adolescent therapy, patients were treated to normal-
weight status. Further, as we investigated patients who
mostly suffered for many years from AN symptoms,
smaller weight change has to be expected than in adoles-
cent patients whose eating disorder just emerged. Hence,
the pre-post change in BMI was much larger in thischange at therapy entrance predicting therapeutic
95% CI
p Lower bound Upper bound R2
.45
.13 .272 −.60 2.81
.54 .020 .07 .73
.44 .025 .06 .76
.40
2 .61 −1.05 1.75
.42 .026 .06 .87
.12 .047 .01 .81
tional bond at the end of therapy. Model 2 = stages of change at baseline
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nantly chronic adult sample (14.9 to 16.2), which re-
ceived on average much shorter inpatient treatment.
Hence, more potential variance remains to be explained
in weight gain in the study by Castro-Fornieles et al.,
which probably is responsible for the better predictive
value of stages of change on BMI. However, it is gene-
rally difficult to evaluate our finding on weight gain as
evidence on stages of change in adult samples is scarce
[9]. Further research is needed to investigate the predict-
ive value of stages of change on weight gain as a pivotal
aim and outcome of AN treatment.
Turning to the predictive effect of stages of change at
therapy entrance on therapeutic alliance on discharge,
we identified significant predictive effects of the contem-
plation scale on both emotional bond and agreement on
collaboration at discharge. This is in line with earlier evi-
dence [19], where contemplation at baseline predicted
positive therapeutic alliance at session one and session
three in a sample of sixty patients with mixed psychiatric
diagnoses. Although precontemplation at therapy en-
trance did correlate significantly and negatively with
emotional bond and agreement on collaboration at dis-
charge, it was not a significant predictor in the regres-
sion analyses when controlled for the autoregressor. AN
patients often value many aspects of their disorder [5]
and therefore are at least in parts or periodically charac-
terized by precontemplation with regard to therapeutic
change. This constitutes a major difficulty in AN treat-
ment and assigns therapists with the motivational task
to challenge precontemplation and try to induce contem-
plation in patients. Techniques of Motivational Inter-
viewing [8] have been specifically designed to address
this aspect and to reach patients in between precontem-
plation and contemplation. Our data shows that contem-
plation is a predictor of a positive therapeutic alliance in
the course of inpatient treatment. This might lead to the
conclusion that early intervention strategies to induce
contemplation in AN inpatients are not only important
for therapeutic change, but might also form a basis for a
stable therapeutic alliance that even allows for the com-
mon cautious exploration of further stages of change in
the course of treatment [8].
Our study implied several limitations as discussed
hereafter. First, the URICA is sensitive to identify relap-
ses, but it is not a disorder-specific instrument. Hence,
in future studies it might be important to address pa-
tients’ relapse threats with a disorder-specific measure.
The Anorexia Nervosa Stages of Change Questionnaire
(ANSOCQ) [27] is an instrument measuring stages of
change specifically in AN patients. In contrast to the
URICA, where the maintenance score reflects relapse
struggle, in the ANSOCQ, this score refers to the ability
to maintain progress [12,14]. Nevertheless, as we haveoutlined above, relapse measures are of importance con-
cerning AN research, because high rates of relapses
are critical elements in AN treatment [15]. Therefore, it
might be of interest to phrase a new, more differentiated
disorder-specific stage-of-change scale, containing a pro-
gress maintenance as well as a relapse subscale. Second,
our study predominantly included chronic inpatients. Ef-
fects of stages of change on outpatients and non-chronic
patients might be different. Third, we only applied a
measure of general psychopathology as a symptomatic
outcome instrument. Future studies should investigate
stages of change outcome associations with measures
that are more specific to the eating disorder symptoms,
which are at the core of AN. Fourth, the duration of in-
patient treatment varied across participants. Treatment
duration might influence the quality of therapeutic alli-
ance. More specifically, in our sample, patients with
longer versus shorter treatment duration expressed
slightly higher therapeutic alliance ratings. As sample
size in our study was too small to analyze further differ-
ences between these two groups, future research should
address this aspect in studies with larger sample sizes.
Conclusion
To sum up, our study was the first to investigate diffe-
rent motivational profiles on discrete stages of change as
well as associations of stages of change and therapeutic
alliance in adult inpatients with a long-lasting history of
AN. We demonstrated that relapse risk as operationa-
lized by the maintenance scale of the URICA-S is an im-
portant predictor of general psychopathology over the
course of inpatient treatment in AN patients. In line
with earlier evidence, contemplation significantly pre-
dicted therapeutic alliance. The URICA-S maintenance
scale might be applied as a relapse identification tool.
Future research should address this aspect in rando-
mized clinical trials.
Appendix
Items of the URICA-S maintenance scale
It worries me that I might slip back on a problem I have
already changed, so I am here to seek help. / I'm not fol-
lowing through with what I had already changed as well
as I hoped, and I'm here to prevent a relapse of the
problem. / I'm here to prevent myself from having a re-
lapse of my problem. / It is frustrating, but I feel I might
be having a recurrence of a problem I thought I had
resolved.
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